SLC45A2
(Solute Carrier Family 45, Member 2 (SLC45A2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-SLC45A2 antibody (Catalog #: ARP43780_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SLC45A2
(Solute Carrier Family 45, Member 2 (SLC45A2))
Synonyme
SLC45A2 Peptide, matp Peptide, aim1 Peptide, im:7138762 Peptide, MGC114950 Peptide, 1A1 Peptide, AIM1 Peptide, MATP Peptide, OCA4 Peptide, SHEP5 Peptide, Aim-1 Peptide, Aim1 Peptide, Dbr Peptide, Matp Peptide, blanc-sale Peptide, bls Peptide, uw Peptide, solute carrier family 45 member 2 Peptide, solute carrier family 45, member 2 Peptide, solute carrier family 45 member 2 L homeolog Peptide, SLC45A2 Peptide, slc45a2 Peptide, slc45a2.L Peptide, Slc45a2 Peptide
Hintergrund
SLC45A2 is a melanocyte differentiation antigen that is expressed in a high percentage of melanoma cell lines. A similar sequence gene in medaka, 'B,' encodes a transporter that mediates melanin synthesis. Mutations in this gene are a cause of oculocutaneous albinism type 4.The protein encoded by this gene encodes a melanocyte differentiation antigen that is expressed in a high percentage of melanoma cell lines. A similar sequence gene in medaka, 'B,' encodes a transporter that mediates melanin synthesis. Mutations in this gene are a cause of oculocutaneous albinism type 4. Alternative splicing results in multiple transcript variants encoding different isoforms.